01 1The Division of Cancer Treatment and Diagnosis
01 1DRUG DEVELOPMENT PROGRAM
01 1U.S.A
01 1Inactive
01 1Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 724
Submission : 1963-03-07
Status : Inactive
Type : II
20
National Cancer Institute, based in U.S.A, is a pharmaceutical company.
One of their notable products is DRUG DEVELOPMENT PROGRAM, with a corresponding US DMF Number 724.
Remarkably, this DMF maintains an Inactive status since its submission on March 07, 1963, highlighting commitment to regulatory compliance.
